Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-06-07
2000-05-16
Duffy, Patricia A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530300, 530324, 530350, A01N 3718, A61K 3800
Patent
active
060637552
ABSTRACT:
Intestinal trefoil factors and nucleic acids encoding intestinal trefoil factors are disclosed. The intestinal trefoil factors disclosed are resistent to destruction in the digestive tract and can be used for the treatment of peptic ulcer diseases, inflammatory bowel diseases and other insults.
REFERENCES:
Suemori et al., "Identification and characterization of rat intestinal trefoil factor: Tissue- and cell-specific . . . ", Proc. Natl. Acad. Sci., 88:11017-11021 (1991).
Parson, J.A. (Editor) "Peptide Hormones", published by University Park Press see Chapter 1, pp 1-7 by Rudinger, Jun. 1976.
Lazar et al. Mol. Cell. Biology 8(3):1247-52, Mar. 1988.
Burgess et al. J. Cell Biol. 111:2129-38, Nov. 1990.
Babyatsky, M.W. et al. Gastroenterology, vol. 106, No. 4, p. A43 (abstract), Apr. 1994.
Maniatis, T., et al. 1982, Molecular Cloning, A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Habor, New York, pp. 224-246, 270-307, 310-352, 404-433.
Jorgensen, K.D., et al., 1982, Pancreatic Spasmolytic Polypeptide (PSP): III. Pharmacology of a new porcine pancreatic polypeptide with spasmolytic and gastric acid secretion inhibitory effects, Reg.Pep. 3:231-243.
Thim, L., et al., 1982, Pancreatic Spasmolytic Polypeptide (PSP): II. Radioimmunological determination of PSP in porcine tissues, plasma and pancreatic juice, Regulatory Peptides, 3:221-230.
Jorgensen, K.H., et al., 1982, Pancreatic Spasmolytic Polypeptide (PSP): I. Preparation and initial chemical characterization of a new polypeptide from porcine pancreas, Regulatory Peptides, 3:207-219.
Jakowlew, S.B., et al., 1984, Sequence of the pS2 mRNA induced by estrogen in the human breast cancer cell line MCF-7, 12:2861-2878.
Frandsen, E.K., et al., 1986, Receptor binding of pancreatic spasmolytic polypeptide (PSP) in rat intestinal mucosal cell membranes inhibits the adenylate cyclase activity, Regulatory Peptides, 16:291-297.
Rio, M.C., et al., 1988, Breast Cancer-Associated pS2 Protein: Synthesis and Secretion by Normal Stomach Mucosa, Science, 241:705-708.
Podolsky, D.K., et al., 1988, Latent Transformed Growth-inhibiting Factor in Human Malignant Effusions, Cancer Research, 48:418-424.
Duffy Patricia A.
The General Hospital Corporation
LandOfFree
Intestinal trefoil proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Intestinal trefoil proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intestinal trefoil proteins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-258898